Miao, Y., Dobre, D., Lambers Heerspink, H. J., Brenner, B. M., Cooper, M. E., Parving, H., . . . de Zeeuw, D. (2010). Increased serum potassium affects renal outcomes: A post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. Springer-Verlag.

Miao, Y., D. Dobre, H. J. Lambers Heerspink, B. M. Brenner, M. E. Cooper, H-H Parving, S. Shahinfar, D. Grobbee, and D. de Zeeuw. Increased Serum Potassium Affects Renal Outcomes: A Post Hoc Analysis of the Reduction of Endpoints in NIDDM With the Angiotensin II Antagonist Losartan (RENAAL) Trial. Springer-Verlag, 2010.

Miao, Y., et al. Increased Serum Potassium Affects Renal Outcomes: A Post Hoc Analysis of the Reduction of Endpoints in NIDDM With the Angiotensin II Antagonist Losartan (RENAAL) Trial. Springer-Verlag, 2010.